Optometry and Vision Science最新文献

Significance: Psychometric questionnaires are highly valuable instruments in clinical practice as they make subjective symptoms easier to measure. Recently, a short version of the Ocular Surface Disease Index (OSDI) questionnaire was developed, named OSDI-6.

Purpose: This study aimed to assess the psychometric properties and compare the diagnostic criteria of three questionnaires, available in the Italian language, designed for assessing dry eye disease: Standard Patient Evaluation of Eye Dryness (SPEED), OSDI-12, and specifically the new shortened version, OSDI-6.

Methods: Psychometric evaluations were conducted on 250 adult participants aged 20 to 83 years. Classic and Rasch psychometric analyses were performed on the three questionnaires. The repeatability of the questionnaires was assessed by retesting 120 participants.

Results: The exploratory factor analysis of OSDI-6 indicated saturation on two factors. Repeatability was optimal for all three questionnaires. Based on the reference OSDI-12, the cutoff for OSDI-6 was 5 points and 7 for SPEED. Rasch analysis showed that OSDI-6 and OSDI-12 present disordered response categories and thresholds. Conversely, the SPEED questionnaire shows the optimal item characteristic curve.

Conclusions: The OSDI-12 is a reference questionnaire used in dry eye disease studies and clinics, but OSDI-6 does not represent a perfect shortened version, primarily for the absence of one factor measured and secondarily for the same problem of category response order and thresholds. Conversely, SPEED focusing only on symptoms showed better psychometric properties.

Significance: People with peripheral field loss report colliding with other pedestrians on their blind side(s). We show that, in dyadic collision scenarios between persons, one with field loss, such as homonymous hemianopia, and the other normally sighted pedestrian, collisions occur only if the persons with homonymous hemianopia are overtaking the pedestrians, and the collision risk is concentrated at farther bearing angles than previously suggested.

Purpose: Prior work computed the risk of collision while simulating both pedestrians as points and did not consider the ability of the other pedestrian's normal vision to avoid the collision. We extended the model to better characterize the open space collision risk posed for persons with homonymous hemianopia by normally sighted pedestrians where both have volume.

Methods: We computed the risk of collision with approaching pedestrians using a model that simulates approaching pedestrians as volumetric entities without vision, volumetric entities with vision, and as points for comparison with the prior work. Collision risk of approaching pedestrians is characterized for all three conditions through spatial collision risk maps and collision risk densities as a function of bearing and radial distances.

Results: The collision risk for volumetric pedestrians is slightly different from that of point pedestrians. For volumetric pedestrians simulated with normal vision, the risk of collision was reduced substantially, as the other pedestrians could detect and avoid most impending collisions. The remaining collision risk is from pedestrians approaching at higher bearing angles (>50°) and from shorter radial distances (<2 m). Thus, collisions occurred when the pedestrians started in front of the person with homonymous hemianopia that was overtaking the pedestrian.

Conclusions: The probability of collisions between pedestrians and the person with peripheral field loss is low and occurs only when the person with peripheral field loss is walking from behind the pedestrian at faster speed, thereby overtaking them. Such collisions occur with pedestrians at higher bearing angles, which should be monitored by assistive aids to avoid collisions. The same collision risk applies not only in homonymous hemianopia but also in other peripheral field loss such as monocular vision loss or concentric field loss, as common in retinitis pigmentosa and glaucoma.

Significance: Our retinal image-based deep learning (DL) cardiac biological age (BioAge) model could facilitate fast, accurate, noninvasive screening for cardiovascular disease (CVD) in novel community settings and thus improve outcome with those with limited access to health care services.

Purpose: This study aimed to determine whether the results issued by our DL cardiac BioAge model are consistent with the known trends of CVD risk and the biomarker leukocyte telomere length (LTL), in a cohort of individuals from the UK Biobank.

Methods: A cross-sectional cohort study was conducted using those individuals in the UK Biobank who had LTL data. These individuals were divided by sex, ranked by LTL, and then grouped into deciles. The retinal images were then presented to the DL model, and individual's cardiac BioAge was determined. Individuals within each LTL decile were then ranked by cardiac BioAge, and the mean of the CVD risk biomarkers in the top and bottom quartiles was compared. The relationship between an individual's cardiac BioAge, the CVD biomarkers, and LTL was determined using traditional correlation statistics.

Results: The DL cardiac BioAge model was able to accurately stratify individuals by the traditional CVD risk biomarkers, and for both males and females, those issued with a cardiac BioAge in the top quartile of their chronological peer group had a significantly higher mean systolic blood pressure, hemoglobin A 1c , and 10-year Pooled Cohort Equation CVD risk scores compared with those individuals in the bottom quartile (p<0.001). Cardiac BioAge was associated with LTL shortening for both males and females (males: -0.22, r2 = 0.04; females: -0.18, r2 = 0.03).

Conclusions: In this cross-sectional cohort study, increasing CVD risk whether assessed by traditional biomarkers, CVD risk scoring, or our DL cardiac BioAge, CVD risk model, was inversely related to LTL. At a population level, our data support the growing body of evidence that suggests LTL shortening is a surrogate marker for increasing CVD risk and that this risk can be captured by our novel DL cardiac BioAge model.

Significance: Imposing a time limit on the Farnsworth D15 test may prevent patients from compromising the test.

Purpose: This study aimed to investigate the effect of test time on the Farnsworth D15 color vision test in unpracticed and practiced subjects and determine an optimal test time.

Methods: Twenty-one subjects (mean/standard deviation age, 33.1/9.3 years) with a range of congenital color vision deficiency participated in the study. Pseudoisochromatic plate screening, Farnsworth D15, and anomaloscope testing were performed for classification purposes. At each of 2 visits, 10 trials of the Farnsworth D15 were performed with a range in test times from 30 seconds to 10 minutes. Between visits, subjects practiced the test. Major crossovers were used as the outcome measure. A repeated-measures analysis of variance compared the scores across trials. Post hoc Dunnett's testing analyzed the pairwise data.

Results: Although no significant difference in the mean number of major crossovers was found across the 10 trials for the first visit ( F (9, 180) = 1.30, p=0.24), a significant difference was found for the second visit ( F (9, 180) = 4.77, p<0.001). The range of mean number of major crossovers for the second visit was 1.71 to 5.1, with the 30-second trial resulting in the largest number of major crossovers and the longest trial resulting in the smallest number of major crossovers. Analysis showed that a 2-minute time limit resulted in a Farnsworth D15 outcome that would be expected based on the anomaloscope for a majority of subjects.

Conclusions: In this study, test time was found to affect performance in practiced subjects but not in unpracticed subjects. Based on this study, we recommend enforcing a time limit of 2 minutes to discourage those who try to pass the Farnsworth D15 through practice. Additional measures, such as recording patient behavior, can also be taken.

Significance: Angular Indication Measurement (AIM) is an adaptive, self-administered, and generalizable orientation-judgment method designed to interrogate visual functions. We introduce AIM Visual Acuity (VA) and show its features and outcome measures. Angular Indication Measurement VA's ability to detect defocus was comparable with that of an Early Treatment of Diabetic Retinopathy Study (ETDRS) letter chart and showed greater sensitivity to astigmatic blur.

Purpose: This proof-of-concept study introduces Angular Indication Measurement and applies it to VA.

Methods: First, we compared the ability of AIM-VA and ETDRS to detect defocus and astigmatic blur in 22 normally sighted adults. Spherical and cylindrical lenses in the dominant eye induced blur. Second, we compared repeatability over two tests of AIM-VA and ETDRS.

Results: A repeated-measure analysis of variance showed a main effect for defocus blur and test. For the astigmatism experiment, an interaction between blur and orientation was found. Pairwise comparisons showed that AIM was more sensitive to astigmatic-induced VA loss than ETDRS. Bland-Altman plots showed small bias and no systematic learning effect for either test type and improved repeatability with more than two adaptive steps for AIM-VA.

Conclusions: Angular Indication Measurement VA's ability to detect defocus was comparable with that of an ETDRS letter chart and showed greater sensitivity to induced astigmatic blur, and AIM-VA's repeatability is comparable with ETDRS when using two or more adaptive steps. Angular Indication Measurement's self-administered orientation judgment approach is generalizable to interrogate other visual functions, e.g., contrast, color, motion, and stereovision.